Wire · regulatory
FDA Introduces a Potential Review Architecture for Generative AI-Enabled Medical Devices
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 25 August 2026 · Fusion42 review
The FDA published a discussion paper proposing a two-axis risk framework and competency-based premarket evaluation for generative AI-enabled medical devices, seeking public feedback by October 19, 2026.
This Wire brief sits within Fusion42's coverage of Medtech, and 14 sources have reported it between 18 Aug 2026 and 15 Sep 2026.
◆ ◆ The Wire takeaway
You must prepare your generative AI medical device for competency-based evaluation involving clinical benchmarking and tailored risk assessments. Early engagement in the FDA's feedback process creates a path to shape approval criteria before these regulatory demands solidify.
◆ Coverage
14 sources · first reported 18 Aug 2026 · latest 15 Sep 2026
◆ Related on Wire
◆ Topics